Načítá se...
Ligandomics: a paradigm shift in biological drug discovery
As productivity of pharmaceutical research and development (R&D) for small-molecule drugs declines, the trend in drug discovery strategies is shifting towards biologics, which predominantly target secreted or cell surface proteins. Receptors and ligands are the most-valuable drug targets. In con...
Uloženo v:
| Vydáno v: | Drug Discov Today |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849512/ https://ncbi.nlm.nih.gov/pubmed/29326083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2018.01.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|